The two major breast cancer susceptibility genes, BRCA1 and BRCA2, account for the majority of familial breast–ovarian cancer, but only a modest proportion of breast cancer families without ovarian or male breast cancer. Search for additional breast cancer genes with traditional linkage analysis has so far been unsuccessful, probably due to genetic heterogeneity. Pooling of families of different ethnical, cultural, and geographical origin proved to be a useful approach when identifying BRCA1 and BRCA2, but for genes mutated only in specific populations it is important not to introduce locus heterogeneity by pooling. Genetic heterogeneity can possibly be circumvented by using objective means, such as tumour histopathology or gene expression ...
Breast cancer is a heterogeneous disease for which the existence of monogenic and polygenic models o...
The heterogeneity of multiple case breast cancer families that do not carry mutations in BRCA1 or BR...
Breast cancer is the most common female malignancy in the Western world and approximately 510% of al...
The contribution of BRCA1 and BRCA2 to inherited breast cancer was assessed by linkage and mutation ...
In the decade since their discovery, the two major breast cancer susceptibility genes BRCA1 and BRCA...
SummaryThe contribution of BRCA1 and BRCA2 to inherited breast cancer was assessed by linkage and mu...
Item does not contain fulltextPURPOSE: Since the identification of BRCA1 and BRCA2, there has been n...
Germline mutations in BRCA1 and BRCA2 explain approximately 25% of all familial breast cancers. Desp...
Item does not contain fulltextGermline mutations in BRCA1 and BRCA2 explain approximately 25% of all...
PURPOSE: Since the identification of BRCA1 and BRCA2, there has been no major breast cancer suscepti...
Mutations in known breast cancer susceptibility genes account for a minority of the familial aggrega...
Mutations in known breast cancer susceptibility genes account for a minority of the familial aggrega...
Mutations in known breast cancer susceptibility genes account for a minority of the familial aggrega...
Mutations in known breast cancer susceptibility genes account for a minority of the familial aggrega...
Genetic predisposition is responsible for 5%-10% of all breast cancer cases. Therefore, the inherite...
Breast cancer is a heterogeneous disease for which the existence of monogenic and polygenic models o...
The heterogeneity of multiple case breast cancer families that do not carry mutations in BRCA1 or BR...
Breast cancer is the most common female malignancy in the Western world and approximately 510% of al...
The contribution of BRCA1 and BRCA2 to inherited breast cancer was assessed by linkage and mutation ...
In the decade since their discovery, the two major breast cancer susceptibility genes BRCA1 and BRCA...
SummaryThe contribution of BRCA1 and BRCA2 to inherited breast cancer was assessed by linkage and mu...
Item does not contain fulltextPURPOSE: Since the identification of BRCA1 and BRCA2, there has been n...
Germline mutations in BRCA1 and BRCA2 explain approximately 25% of all familial breast cancers. Desp...
Item does not contain fulltextGermline mutations in BRCA1 and BRCA2 explain approximately 25% of all...
PURPOSE: Since the identification of BRCA1 and BRCA2, there has been no major breast cancer suscepti...
Mutations in known breast cancer susceptibility genes account for a minority of the familial aggrega...
Mutations in known breast cancer susceptibility genes account for a minority of the familial aggrega...
Mutations in known breast cancer susceptibility genes account for a minority of the familial aggrega...
Mutations in known breast cancer susceptibility genes account for a minority of the familial aggrega...
Genetic predisposition is responsible for 5%-10% of all breast cancer cases. Therefore, the inherite...
Breast cancer is a heterogeneous disease for which the existence of monogenic and polygenic models o...
The heterogeneity of multiple case breast cancer families that do not carry mutations in BRCA1 or BR...
Breast cancer is the most common female malignancy in the Western world and approximately 510% of al...